alpinetin has been researched along with Lung Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, C; Guo, B; Hou, S; Yuan, Q; Yuan, X; Zhang, Z | 1 |
| Lu, JB; Wu, L; Yang, W; Zhang, SN | 1 |
2 other study(ies) available for alpinetin and Lung Neoplasms
| Article | Year |
|---|---|
Alpinetin delays high-fat diet-aggravated lung carcinogenesis.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Diet, High-Fat; Female; Flavanones; Lipid Metabolism; Lung Neoplasms; Macrophages; Mice; Mice, Inbred C57BL | 2021 |
Alpinetin inhibits lung cancer progression and elevates sensitization drug-resistant lung cancer cells to cis-diammined dichloridoplatium.
Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; Cisplatin; Disease Progression; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Flavanones; Humans; Lung Neoplasms; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; Structure-Activity Relationship; Tumor Cells, Cultured | 2015 |